Jove
Visualize
联系我们

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Factors influencing accelerated progression in behavioral variant frontotemporal dementia.

Journal of neurology·2026
Same author

Adherence to Life's Essential 8 enhances gut microbiota diversity and cognitive performance.

Frontiers in microbiomes·2026
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same journal

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Stephanie Yiallourou1, Tiffany F Kautz2, Julie Parker-Garza3

  • 1School of Psychological Sciences & Turner Institute for Brain and Mental Health, Monash University, Melbourne, VIC, Australia.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
概括
此摘要是机器生成的。

像pTau217这样的等离子体生物标志物在区分阿尔茨海默病 (AD) 和前性痴呆症 (FTD) 方面表现有前途. 使用这些标记器的机器学习模型有助于早期诊断,尽管对于利维体/帕金森病痴呆症需要进一步改进.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 生物标志物研究 生物标志物研究
  • 机器学习在医学中的应用

背景情况:

  • 血生物标志物在阿尔茨海默病 (AD) 检测方面是有效的,但在区分痴呆症亚型方面尚未得到充分研究.
  • 早期对阿尔茨海默病,前性痴呆症 (FTD) 和莱维体/帕金森病 (LBD/PD) 痴呆症的差异诊断具有挑战性.
  • 本研究评估了等离子体生物标志物,以使用机器学习来区分这些早期痴呆症亚型.

研究的目的:

  • 评估血生物标志物的有效性,以区分AD,FTD和LBD/PD痴呆症.
  • 采用机器学习算法来提高诊断准确度.
  • 确定有助于差异性痴呆症诊断的关键血生物标志物.

主要方法:

  • 招募了患有早期AD,FTD和LBD/PD痴呆症的患者.
  • 使用Simoa和MSD平台对Aβ40,Aβ42,pTau181,pTau217,TDP-43,NfL,GFAP和YKL40进行了血分析.
  • 使用SuperLearner算法开发了痴呆症亚型分类模型,结合年龄,性别和所有血生物标志物,通过AUC进行评估.

主要成果:

  • 结合所有生物标志物的机器学习模型实现了AD (AUC=0.84) 和FTD (AUC=0.85) 与其他痴呆症的优秀歧视.
  • 对于LBD/PD痴呆症 (AUC=0.72) 观察到中等程度的歧视.
  • pTau217是AD分化最强的个人预测因素;NfL显示FTD的贡献最高,由标记物的组合驱动.

结论:

  • pTau217是区分AD的关键血生物标志物.
  • FTD分类依赖于生物标志物的组合,NfL显示了最高的个人贡献.
  • 血生物标志物显示出早期,非侵入性AD和FTD差异诊断的显著潜力,对于LBD/PD需要进一步优化.